and fiber supplements to meet daily requirements for this key macronutrient as appetite decreases
Cytotoxin from N
Last Published 10.01.2025 Effective Date: 10.01.2025 This policy addresses certain medical benefit medications that are healthcare provider administered and have been deemed therapeutically equivalent
Semaglutide is also approved for weight management in people battling obesity, especially those with a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or above when paired with weight-related conditions such as high cholesterol, type 2 diabetes, or hypertension
Hormonal & metabolic balance*
Randomization was stratified according to background diabetes treatment: diet and physical activity only, or treatment with metformin or SGLT-2 inhibitor monotherapy, or sulfonylurea or glitazone monotherapy or combination therapy with up to 3 oral antidiabetic drugs (OADs) (metformin, sulfonylureas, SGLT-2 inhibitors, or glitazone)